Exact Mass: 502.1686

Exact Mass Matches: 502.1686

Found 63 metabolites which its exact mass value is equals to given mass value 502.1686, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Clozapine glucuronide

(2R,3R,4R,5S,6S)-6-[6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaen-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H27ClN4O6 (502.1619)

Clozapine glucuronide is a metabolite of clozapine. Clozapine (sold as Clozaril, Gen-Clozapine in Canada, Azaleptin, Leponex, Fazaclo, Froidir; Denzapine, Zaponex in the UK; Klozapol in Poland, Clopine in Australia and New Zealand) is an atypical antipsychotic medication used in the treatment of schizophrenia, and is also used off-label in the treatment of bipolar disorder. Wyatt. R and Chew. (Wikipedia)

Adozelesin

N-(2-{3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.0¹,¹².0²,⁶]trideca-2(6),3,8-triene-10-carbonyl}-1H-indol-5-yl)-1-benzofuran-2-carboxamide

C30H22N4O4 (502.1641)

Inolitazone

5-[(4-{[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-1,3-benzodiazol-2-yl]methoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione

C27H26N4O4S (502.1675)

C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D000970 - Antineoplastic Agents

2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide

2-{4-[2-(1H-1,3-benzodiazol-2-ylsulphanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulphanyl)pyridin-3-yl]ethanimidic acid

C23H30N6OS3 (502.1643)

D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D004791 - Enzyme Inhibitors

Demethoxyisogemichalcone C

3- (4-Coumaroyloxy-3-methylbutyl-2 (E) -enyl) -2,4,2,4-tetrahydroxychalcone

C29H26O8 (502.1628)

bromophycolide R

C27H35BrO4 (502.1719)

mersiloscine

C24H26N2O10 (502.1587)

Sibirioside B

C22H30O13 (502.1686)

macrostachyol C

C29H26O8 (502.1628)

6-O-apio-beta-furanosyl-[5-O-(trans-dimethoxycinnamic acid)]-alpha/beta-glucopyranoside

C22H30O13 (502.1686)

10-O-(4-O-methylsuccinoyl)geniposide|[(1S,4aS,7aS)-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydro-4-(methoxycarbonyl)-cyclopenta[c]pyran-7-yl]methyl methyl butanedioate

C22H30O13 (502.1686)

3-[(4-O-caffeoyl-beta-D-glucopyranosyloxy)methyl]-2,5-dimethoxy-3-hydroxytetrahydrofuran|cibotiumbaroside B

C22H30O13 (502.1686)

bromophycolide L

C27H35BrO4 (502.1719)

3-[??-Hydroxymethyl-(E)-??-methylallyl]-2,4,2,4-tetrahydroxychalcone 11-O-coumarate|isogemichalcone B

C29H26O8 (502.1628)

(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl 6-O(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside|clemomandshuricoside B

C22H30O13 (502.1686)

3-CHLORO-8β-HYDROXYCARAPIN, 3,8-HEMIACETAL

C27H31ClO7 (502.1758)

Netropsin dihydrochloride

C18H28Cl2N10O3 (502.1723)

congocidine

C18H28Cl2N10O3 (502.1723)

9-Nitro Minocycline Sulfate Salt (85\\%)

C23H26N4O9 (502.17)

Clozapine-5-N-Glucuronide

C24H27ClN4O6 (502.1619)

amicoumacin A 2-phosphate

C20H29N3O10P- (502.159)

(2R)-2-amino-4-[4-[(1R)-2-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]amino]-1-(hydroxyamino)-2-oxoethyl]phenoxy]butanoic acid

C23H26N4O9 (502.17)

Clozapine glucuronide

C24H27ClN4O6 (502.1619)

3-(4-methylphenyl)-N-[3-(4-morpholinylsulfonyl)phenyl]-1-phenyl-4-pyrazolecarboxamide

C27H26N4O4S (502.1675)

2-Hydroxy-5-[(4-methoxyphenyl)sulfamoyl]benzoic acid [2-[1-(3-bicyclo[2.2.1]heptanyl)ethylamino]-2-oxoethyl] ester

C25H30N2O7S (502.1774)

3-(4-{7-[(5-carboxypentyl)(ethyl)amino]-2-oxo-2H-chromen-3-yl}pyridinium-1-yl)propane-1-sulfonate

C25H30N2O7S (502.1774)

[(4R)-4-[2-(benzenesulfonyl)ethyl]-2-[4-(3-hydroxypropoxy)phenyl]-5H-oxazol-4-yl]-(4-morpholinyl)methanone

C25H30N2O7S (502.1774)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide

C25H30N2O7S (502.1774)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide

C25H30N2O7S (502.1774)

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide

C25H30N2O7S (502.1774)

2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide

C25H30N2O7S (502.1774)

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide

C25H30N2O7S (502.1774)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide

C25H30N2O7S (502.1774)

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide

C25H30N2O7S (502.1774)

Arg-AMS

C16H26N10O7S (502.1707)

Arg-AMS (compound 24) is a potent nanomolar inhibitor of arginyl tRNA synthetase, which displays tightly bound inhibitory characteristics for the A-domains in non-ribosomal peptide synthetases (NRPS) enzymes[1].

3,22-dimethoxy-13-methyl-12-methylidene-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(22),2(10),3,8,15,17(21)-hexaen-11-yl benzoate

C29H26O8 (502.1628)

(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-{[(2r,3s,5s)-3-hydroxy-2,5-dimethoxyoxolan-3-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C22H30O13 (502.1686)

(3s)-3-hydroxy-5-{[(2e)-3-(3-hydroxy-5-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-en-1-yl]oxy}-3-methyl-5-oxopentanoic acid

C22H30O13 (502.1686)

(2r,3r,4r,5r,6r)-4,5-dihydroxy-6-{[(2r,3s,5s)-3-hydroxy-2,5-dimethoxyoxolan-3-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C22H30O13 (502.1686)

3'-[γ-hydroxymethyl-(e)-γ-methylallyl]-2,4,2',4'-tetrahydroxychalcone 11'-o-coumarate

C29H26O8 (502.1628)

{"Ingredient_id": "HBIN009772","Ingredient_name": "3'-[\u03b3-hydroxymethyl-(e)-\u03b3-methylallyl]-2,4,2',4'-tetrahydroxychalcone 11'-o-coumarate","Alias": "NA","Ingredient_formula": "C29H26O8","Ingredient_Smile": "CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=C(C=C(C=C2)O)O)O)COC(=O)C=CC3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10505","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

methyl 6-[(1s)-1-[4-(methoxycarbonyl)phenazin-1-yl]ethyl]phenazine-1-carboxylate

C30H22N4O4 (502.1641)

(1r,2s,3r)-2-(2,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-1-[(r)-(4-hydroxyphenyl)(methoxy)methyl]-2,3-dihydro-1h-indene-4,6-diol

C29H26O8 (502.1628)

(11r,12s,15s)-11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one

C27H35BrO4 (502.1719)

19,21-dimethyl (2r,4s,9r,21r,22r,23r,25r)-21,22,23-trihydroxy-3,14,16-trioxa-6,19-diazaoctacyclo[18.2.2.1¹,⁶.0²,⁴.0⁹,²⁰.0¹⁰,¹⁸.0¹³,¹⁷.0⁹,²⁵]pentacosa-10(18),11,13(17)-triene-19,21-dicarboxylate

19,21-dimethyl (2r,4s,9r,21r,22r,23r,25r)-21,22,23-trihydroxy-3,14,16-trioxa-6,19-diazaoctacyclo[18.2.2.1¹,⁶.0²,⁴.0⁹,²⁰.0¹⁰,¹⁸.0¹³,¹⁷.0⁹,²⁵]pentacosa-10(18),11,13(17)-triene-19,21-dicarboxylate

C24H26N2O10 (502.1587)

(8r,11r,12s,15s)-11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one

C27H35BrO4 (502.1719)

4,5-dihydroxy-6-[(3-hydroxy-2,5-dimethoxyoxolan-3-yl)methoxy]-2-(hydroxymethyl)oxan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C22H30O13 (502.1686)

(3r,7s,8s,11s,13s,16s)-7-bromo-22-hydroxy-8,13-dimethyl-4-methylidene-16-(prop-1-en-2-yl)-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one

C27H35BrO4 (502.1719)

4-{3-[(2e)-3-(2,4-dihydroxyphenyl)prop-2-enoyl]-2,6-dihydroxyphenyl}-2-methylbut-2-en-1-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H26O8 (502.1628)

(11r,13s)-3,22-dimethoxy-13-methyl-12-methylidene-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(22),2(10),3,8,15,17(21)-hexaen-11-yl benzoate

C29H26O8 (502.1628)

(7s,8s,11s,13s,16s)-7-bromo-22-hydroxy-8,13-dimethyl-4-methylidene-16-(prop-1-en-2-yl)-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one

C27H35BrO4 (502.1719)

11,12-dimethyl (1r,12s,13r,16s,19r,24r,25s)-12,25-dihydroxy-17-oxo-6,8,18-trioxa-11,21-diazaheptacyclo[14.7.1.1¹⁶,¹⁹.0¹,¹³.0²,¹⁰.0⁵,⁹.0²¹,²⁴]pentacosa-2(10),3,5(9)-triene-11,12-dicarboxylate

11,12-dimethyl (1r,12s,13r,16s,19r,24r,25s)-12,25-dihydroxy-17-oxo-6,8,18-trioxa-11,21-diazaheptacyclo[14.7.1.1¹⁶,¹⁹.0¹,¹³.0²,¹⁰.0⁵,⁹.0²¹,²⁴]pentacosa-2(10),3,5(9)-triene-11,12-dicarboxylate

C24H26N2O10 (502.1587)

3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C22H30O13 (502.1686)

methyl 6-{1-[4-(methoxycarbonyl)phenazin-1-yl]ethyl}phenazine-1-carboxylate

C30H22N4O4 (502.1641)

11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one

C27H35BrO4 (502.1719)

7-bromo-22-hydroxy-8,13-dimethyl-4-methylidene-16-(prop-1-en-2-yl)-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one

C27H35BrO4 (502.1719)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C22H30O13 (502.1686)

(8s,11r,12s,15s)-11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one

C27H35BrO4 (502.1719)

4-{3-[3-(2,4-dihydroxyphenyl)prop-2-enoyl]-2,6-dihydroxyphenyl}-2-methylbut-2-en-1-yl 3-(4-hydroxyphenyl)prop-2-enoate

C29H26O8 (502.1628)

(11r,13r)-3,22-dimethoxy-13-methyl-12-methylidene-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(22),2(10),3,8,15,17(21)-hexaen-11-yl benzoate

C29H26O8 (502.1628)